肝癌介入治疗新进展  

New progress of interventional therapy for liver cancer

作　　者：徐克[1] 邵海波[1] Xu Ke;Shao Haibo(Department of Radiology,The First Affiliated Hospital of China Medical University,Shenyang 110001,Liaoning,China)

机构地区：[1]中国医科大学附属第一医院放射科,辽宁沈阳110001

出　　处：《肝癌电子杂志》2020年第3期2-6,共5页Electronic Journal of Liver Tumor

摘　　要：肝癌是最常见的恶性肿瘤之一,介入治疗已经成为肝癌重要的治疗手段。肝癌介入治疗已经从最初针对中期肝癌的单纯肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)治疗发展到贯穿不同分期肝癌的多种介入治疗方法。特别是随着近年来介入治疗设备、器材、材料的快速发展,肝癌介入治疗的发展日新月异。本文就TACE、肝动脉放射栓塞、肝癌经皮消融治疗(射频消融、微波消融、冷冻消融、不可逆电穿孔)、放射性粒子近距离治疗、介入治疗联合分子靶向和免疫治疗等方面的最新进展展开述评,并对肝癌介入治疗相关的新药物、新材料、新设备进行展望。As one of the most common malignant tumors, interventional therapy has become an important treatment for liver cancer. The interventional therapy of liver cancer has developed from TACE(transcatheter arterial chemoembolization) to a variety of interventional therapy through different stages of liver cancer. Especially with the rapid development of interventional therapy equipment, and materials in recent years, the development of interventional therapy for liver cancer is changing rapidly. This paper reviews the latest progress in TACE, transcutaneous ablation of liver cancer(radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation), brachytherapy with radioactive particles, interventional therapy combined with molecular targeting and immunotherapy, and looks forward to new drugs, materials and equipment related to interventional therapy of liver cancer.

关 键 词：肝癌 介入治疗 应用进展 

分 类 号：R735.7[医药卫生—肿瘤]